advertisement
Johnson GA 11
Showing records 1 to 11 | Display all abstracts from Johnson GA106617 Neuroprotection of Rodent and Human Retinal Ganglion Cells In Vitro/Ex Vivo by the Hybrid Small Molecule SA-2
Pham JH
Cells 2022; 11:
106361 Peptains block retinal ganglion cell death in animal models of ocular hypertension: implications for neuroprotection in glaucoma
Nam MH
Cell Death and Disease 2022; 13: 958
106617 Neuroprotection of Rodent and Human Retinal Ganglion Cells In Vitro/Ex Vivo by the Hybrid Small Molecule SA-2
Johnson GA
Cells 2022; 11:
106361 Peptains block retinal ganglion cell death in animal models of ocular hypertension: implications for neuroprotection in glaucoma
Stankowska DL
Cell Death and Disease 2022; 13: 958
106617 Neuroprotection of Rodent and Human Retinal Ganglion Cells In Vitro/Ex Vivo by the Hybrid Small Molecule SA-2
Johnson GA
Cells 2022; 11:
106361 Peptains block retinal ganglion cell death in animal models of ocular hypertension: implications for neuroprotection in glaucoma
Johnson GA; Johnson GA
Cell Death and Disease 2022; 13: 958
106617 Neuroprotection of Rodent and Human Retinal Ganglion Cells In Vitro/Ex Vivo by the Hybrid Small Molecule SA-2
Rangan RS
Cells 2022; 11:
106361 Peptains block retinal ganglion cell death in animal models of ocular hypertension: implications for neuroprotection in glaucoma
Nahomi RB
Cell Death and Disease 2022; 13: 958
106617 Neuroprotection of Rodent and Human Retinal Ganglion Cells In Vitro/Ex Vivo by the Hybrid Small Molecule SA-2
Amankwa CE; Acharya S
Cells 2022; 11:
106361 Peptains block retinal ganglion cell death in animal models of ocular hypertension: implications for neuroprotection in glaucoma
Pantcheva MB; Nagaraj RH
Cell Death and Disease 2022; 13: 958
106617 Neuroprotection of Rodent and Human Retinal Ganglion Cells In Vitro/Ex Vivo by the Hybrid Small Molecule SA-2
Stankowska DL
Cells 2022; 11: